Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bio-Techne's annualizedGross Profit for the quarter that ended in Dec. 2023 was $706 Mil.
Bio-Techne's average Total Assets over the quarter that ended in Dec. 2023 was $2,743 Mil. Therefore, Bio-Techne's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 25.75%.
Bio-Techne Gross-Profit-to-Asset % Historical Data
The historical data trend for Bio-Techne's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Bio-Techne Annual Data
Trend
Jun14
Jun15
Jun16
Jun17
Jun18
Jun19
Jun20
Jun21
Jun22
Jun23
Gross-Profit-to-Asset %
27.23
24.70
29.50
33.20
31.21
Bio-Techne Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Gross-Profit-to-Asset %
31.12
32.59
31.26
27.47
25.75
Competitive Comparison
For the Biotechnology subindustry, Bio-Techne's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne Gross-Profit-to-Asset % Distribution
For the Biotechnology industry and Healthcare sector, Bio-Techne's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Bio-Techne's Gross-Profit-to-Asset % falls into.
Bio-Techne Gross-Profit-to-Asset % Calculation
Bio-Techne's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Dec. 2023) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Bio-Techne Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Bio-Techne's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TECH has been successfully added to your 